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Purpose: Moxifloxacin is a third-generation synthetic fluoroquinolone anti-
bacterial agent. It’s antibacterial spectrum includes enteric Gram-(+) rods,
Gram-() rods, atypical bacteria, and anaerobic bacteria. This drug utiliza-
tion evaluation (DUE) study could help to improve increasing efficacy of
pharmacotherapy. Switch of injection Moxifloxacin to oral form will save
medical expense.
Methods: This study is a retrospective cases reviewed study which assessed
Moxifloxacin injection form converted to oral dosage form of Moxifloxacin.
Data collected from 01/04/2014 to 30/06/2014 inpatients using Moxifloxacin
in a regional hospital in Taichung, Taiwan. Inpatients using Moxifloxacin
routinely were included in the study. There were 110 cases recruiting in
this study. Assessment of the cases met the reasonable criteria included in-
dications, doses, frequency of administrations, and seven-day moxifloxacin
injection conversion to oral dosage form rule.
Results: The average age of patients using Moxifloxacin was 67.47  16.24.
According to the bacteria results, 11 people (10%) were Haemophilus influ-
enzae, 9 people in 110 (8.1%) were Staphylococcus aureus, and 8 people
(7.2%) were Klebsiella pneumonia. Sixty-six people (60 %) administered mox-
ifloxacin as the empirical therapy with bacterial culture growth nothing. A
total of 94 people (85.5%) were counted as reasonableness in Moxifloxacin
utilization. There are 49 people (44.5% ) converted from injection to an
oral dosage form of Moxifloxacin in 7 days and 14 people (12.7%) used less
than seven days then converted to an oral dosage form.
Conclusion: This research shows that Moxifloxacin rationality was counted
as 85.5% (94/110), and the conversion ratio for oral dosage forms was
counted as 44.5% (49/110) which is unsatisfactory. By this study, evalua-
tion of patients’ conversion ratio of the injection to oral provided a refer-
ence for the attending physicians. In order to enhance the patient’s
compliance, pharmacotherapy effective and reduce the enormous health
care costs, we expect the conversion rate will be improved and reach
100%.PS 1-002
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Purpose: Purpose of this study was to evaluate utilization appropriate for
the number of cases receving daptomycin in a regional hospital in Taichung,
Taiwan.
Methods: We performed a retrospective descriptive chart review to evaluate
the appropriate utilization of daptomycin. Cases were recruited from an
electronic report for all patients who had received daptomycin between
Jan 2013 and June 2014. Indication, diagnosis, bacterial culture, and doses
information were collected. The daptomycin dosage regimen was appro-
priate for patients according to their renal function. Total boday weight
was used to calculate doses and creatinin clearance (Clcr) calculated by
Cockcroft-Gault Equation. We also evaluated de-escalated therapy occurred
as an indicator of recovery.
Result: In this study, thirty-eight cases in 24 male and 13 female were
included. The average age was 65.49  12.91. Staphylococcus aureus
(MRSA) were isolated in 25 cases with 11 vancomycin MIC>1.5 ug/mL cases.
Enterococcus faecium (VRE) were isolated in 2 cases. Thirteen cases were
diagnosed as osteomylitis, eight cases were bacteremia with MRSA infection,
four were sepsis and septic shock, and three cases were catheter line infec-
tion with MRSA. The average dosage was 7.34  1.65 mg/kg (median 7.14
mg/kg) and average using days were 20  14.78 days (median 15 days). All
cases were performed renal function monitoring. There were 15 cases
with renal dysfunction but one case administering without any adjustment
by Clcr. After completion of daptomycin treatment, twenty-one cases
were de-escalated to oral antibiotics. Moreover, nine cases were considered
as inappropriate since growth nothing in bacteria culture in 5 cases and
other 4 cases with non-methcillin resistance Staphylococcus aureus, non-
vancomycin resistance Enterococcus faecalis, or Acinetobacter baumannii,
respectively.
Conclusion: Daptomycin usage guidance has been established in ensuring
appropriate prescription at the regional hospital. Computerized order
entering system can help infectious disease specialists to review the pre-
scription of daptomycin. It is anticipated that reserving daptomycin appro-
priate in 100%.PS 1-003
SURVEY OF SURGICAL ANTIBIOTIC PROPHYLAXIS PRACTICES OF
SURGEONS IN MANILA DOCTORS HOSPITAL
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Purpose: Surgical antibiotic practice (Surgical Antibiotic Prophylaxis) is one
of the components of antimicrobial stewardship program (AMS) and is
included in the WHO surgical patient safety checklist. Surgical antibiotic
prophylaxis is recommended to prevent, reduce occurrence surgical site in-
fections. Therefore it is important that policies and guidelines on SAP are
enforced.
Methods: The Infectious Disease Section (IDS) and Infection Prevention and
Control Office (IPCO) finalized guidelines on SAP after series of consultations
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icies, IPCO obtained baseline data on SAP practices of surgeons by reviewing
charts of post-surgery patients for four (4) consecutive weeks by utilizing a
form provided by WHO. Seventy five operations were reviewed. Wound class
were classified, SAP practices and compliance of surgeons analyzed.
Results: Of the 75 operations, 37% 40%, 8%, 15% were wound class 1,2,3,4
respectively. SAP were given to 39% of wound class I, 70% of wound class
2, 67% of wound class 3 and 36% of wound class 4.Fifty three percent
(53%) adhere to right timing within 60 minutes before incision with simple
dose only were given to 44%; 40% continued post operatively. In 16% of cases,
SAP was ordered after the operations.Table I Shows the classifications of the 75 operations by wound class
and SAP practice.
Wound class No (%) No. SAP applied
1 28(37) 11(39)
2 30(40) 21(70)
3 6(8) 4(67)
4 11(15) 4(36)
75(100) 40(53)Table II Compliance of surgeons to SAP recommendations.
Timing %
Within 60 mins 53
Dosing
Single dose 44
Post operative dose only 16
Continued post operative 40Conclusion: The preimplementation survey revealed that only 53% of pa-
tients received SAP at the right timing, 44% received single dose but in
44%, antibiotic was continued after operation. A unified guideline for imple-
mentation of SAP is necessary to improve prophylaxis practices of surgeons.PS 1-004
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OPTIONS FOR NON-TYPHOIDAL SALMONELLA INFECTIONS IN SOUTHERN
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Purpose: Fluoroquinolone-resistant non-typhoidal Salmonella is increasing
worldwide. This study was conducted to evaluate whether fluoroquinolones
are still appropriately therapeutic options for non-typhoidal Salmonella in-
fections in southern Taiwan.
Methods: This was a retrospective study at a regional hospital in southern
Taiwan. From 2009 to 2013, all non-typhoidal Salmonella reported from clin-
ical laboratory were enrolled in this study. If multiple isolates were identi-
fied from the same patient during the same hospitalization period, only
the first isolate was enrolled. Antimicrobial susceptibility testing was done
by disk diffusion method. The tested antibiotics included ampicillin, ceftri-
axone, levofloxacin, and trimethoprim-sulfamethoxazole (TMP-SMX). The re-
sults were interpreted according to the criteria recommended by the Clinical
Laboratory Standards Institute. Intermediate result was regard as resistant
in this study.
Results: A total of 122 isolates of non-typhoidal Salmonella were enrolled in
this study. Of the 29 isolates in 2009, the susceptibility rates of ampicillin,
ceftriaxone, levofloxacin, and TMP-SMX were 69%, 96.6%, 100%, and 89.7%,
respectively. Of the 17 isolates in 2010, those were 70.6%, 100%, 100%,
and 88.2%, respectively. Of the 25 isolates in 2011, those were 60%, 100%,
100%, and 76%, respectively. Of the 22 isolates in 2012, those were 54.6%,
95.5%, 100%, and 90.9%, respectively. Of the 29 isolates in 2013, those
were 58.6%, 100%, 100%, and 82.8%, respectively.
Conclusions: As a result of this study, levofloxacin has a susceptibility rate of
100% for non-typhoidal Salmonella from 2009 to 2013, indicating that fluoro-
quinolones are still appropriately therapeutic options for non-typhoidal Sal-
monella infections in southern Taiwan.PS 1-005
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Purpose: Gram-positive coccus (GPC) bacteremia is common clinically, but
it takes several days to have final identification of microorganism and its
antimicrobial susceptibility. Among all the GPCs, early detection of methi-
cillin-resistant Staphylococcus aureus (MRSA) and shorten the duration of
inadequate treatment is a target for decades. The objective of this study
is to apply polymerase chain reaction to rapidly identify MRSA bacteremia
and analyze its effect.
Methods: The study was performed at Far Eastern Memorial Hospital from
July 2012 to June 2014. All cases with blood culture yielding GPC in clusters
and a time to positive blood culture less than 20 hours were considered for
inclusion. BACTEC 9240 automated blood culture system was used. Conven-
tional identification and susceptibility test of GPC was performed, in parallel
to polymerase chain reaction (Cepheid Xpert MRSA/SA Blood Culture Assay),
if patients agreed to join the study. After knowing the PCR results, infectious
disease physician contacts the primary physician and suggests the antimicro-
bial agent. Outcome of patients received PCR was compared to a control
group of patients not receiving PCR.
Results: Eighty-three patients with GPC bacteremia were enrolled, including
36 cases of methicillin- susceptible Staphylococcus aureus (MSSA), 28 of
coagulase negative Staphylococcus (CoNS), and 19 of MRSA. The median
time to final report was 30.6 hours, compared to 84.4 hours with conven-
tional method. The concordance rate of PCR and conventional methods
was 96%. Knowing the PCR result resulted in 24 cases antimicrobial modifica-
tion (29%). We compared 55 patients received PCR with SA bacteremia to a
control group (69 patients) with similar clinical parameters. The chances of
adequate empirical therapy within 48 hours were 73% in the PCR group and
77% in the control group. The 30 day mortality rates were 15% and 10%,
respectively. In a survival analysis combined these two groups, only MRSA
infection had a borderline significance of increased mortality (p Z 0.06).
Performance of PCR did not affect the outcome of patients.
Conclusion: Application of PCR for GPC bacteremia could shorten the time
to final microbiological report for 54 hours and decrease the time of inade-
quate empirical therapy. However, the effect on patients’ outcome could
not be demonstrated in this study.PS 1-006
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Purpose: According to United States Centers for Disease Control Prevention
of surgical site infection clinical guidelines stated in 1999: prophylactic an-
tibiotics must be given within 60 minutes of the operation according to pa-
tient body weight administered relative dose. Cephalosporins and other first
line class were the major prophylactic antibiotics in intravenous route based
on the principle of not more than one day use, such as during surgery more
than 2e4 hours, or excessive bleeding, according to the pharmacokinetics
needing additional antibiotics. Prophylactic antibiotics can reduce surgical
wound infection.
Methods: This reports were divided according to the structure of the surface
quality control processes, procedures and results of surface surface clean
surgical antibiotic prophylaxis to share the use of monitoring mechanisms
to construct the experience:
A. Structures: 1. An increase in the revised “clean surgical antibiotic prophy-
laxis monitoring methods and processes”, 2. Discussing with the Infectious
